BioAge Labs (BIOA) Cash from Operations (2023 - 2026)

BioAge Labs has reported Cash from Operations for 4 years, with the latest figure at 24046000.0 in Q1 2026.

• Quarterly Cash from Operations fell 38.49% year-over-year to 24046000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 88310000.0 (down 65.96% YoY) and the FY2025 annual result came in at 81627000.0, down 58.43% from the prior year.
• Cash from Operations grew to 24046000.0 in Q1 2026 per BIOA's latest filing, from 28251000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 5138000.0 in Q4 2024 and troughed at 28251000.0 in Q4 2025.
• A 4-year average of 16569800.0 and a median of 15912500.0 in 2024 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 39.57% in 2024, then plunged 449.84% in 2025.
• Over 4 years, Cash from Operations stood at 8503000.0 in 2023, then soared by 39.57% to 5138000.0 in 2024, then slumped by 449.84% to 28251000.0 in 2025, then increased by 14.88% to 24046000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 24046000.0, 28251000.0, and 16044000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.